Citigroup Inc Cerevel Therapeutics Holdings, Inc. Transaction History

Citigroup Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$38.96 - $42.75 $23.8 Million - $26.1 Million	-611,060 Reduced 32.24%	1,284,070 $52.5 Million
Q1 2024 May 10, 2024	BUY	$40.88 - $43.27 $56.5 Million - $59.8 Million	1,383,064 Added 270.09%	1,895,130 $80.1 Million
Q4 2023 Feb 09, 2024	BUY	$20.27 - $42.44 $8.68 Million - $18.2 Million	428,280 Added 511.16%	512,066 $21.7 Million
Q3 2023 Nov 09, 2023	BUY	$20.26 - $31.91 $314,171 - $494,828	15,507 Added 22.71%	83,786 $1.83 Million
Q2 2023 Aug 10, 2023	SELL	$23.9 - $35.38 $2.4 Million - $3.56 Million	-100,510 Reduced 59.55%	68,279 $2.17 Million
Q1 2023 May 11, 2023	BUY	$22.82 - $35.32 $1.43 Million - $2.22 Million	62,826 Added 59.29%	168,789 $4.12 Million
Q4 2022 Feb 09, 2023	SELL	$25.35 - $31.96 $852,723 - $1.08 Million	-33,638 Reduced 24.1%	105,963 $3.34 Million
Q3 2022 Nov 10, 2022	BUY	$25.5 - $41.42 $1.55 Million - $2.52 Million	60,738 Added 77.02%	139,601 $3.95 Million
Q2 2022 Aug 10, 2022	BUY	$20.62 - $37.15 $1.2 Million - $2.16 Million	58,159 Added 280.91%	78,863 $2.09 Million
Q1 2022 May 12, 2022	SELL	$23.5 - $35.38 $2.38 Million - $3.59 Million	-101,345 Reduced 83.04%	20,704 $725,000
Q4 2021 Feb 10, 2022	SELL	$29.21 - $44.64 $2.17 Million - $3.32 Million	-74,444 Reduced 37.89%	122,049 $3.96 Million
Q3 2021 Nov 10, 2021	BUY	$21.26 - $38.85 $4.18 Million - $7.63 Million	196,493 New	196,493 $5.8 Million

5.01M

3.3K

Ticker CERE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 155,752,000
Description
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.